National Pharmacopoeia Commission revised the drug standard of Yaobitong capsule and Ginkgo biloba extract

In order to widely solicit opinions from all sectors of the society and enhance the attention, attention and participation of pharmaceutical manufacturers in the proposed revised content of the quality standard, the draft quality standard of Yaobitong capsule, which is to be revised in the 2015 edition of Chinese Pharmacopoeia, is hereby publicized for three months Please study and verify carefully In case of any objection, please send a letter in time with relevant instructions, experimental data and contact information If there is no opinion at the expiration of the publicity period, it shall be deemed that there is no objection to the content of the proposed revised draft Announcement on the proposed revision standard of Ginkgo biloba extract, Volume I, Chinese Pharmacopoeia, 2015 In order to widely solicit opinions from all sectors of the society and enhance the attention, attention and participation of pharmaceutical manufacturers in the proposed revision of the quality standard, the proposed revision draft of the quality standard of Ginkgo biloba extract, part I of Chinese Pharmacopoeia (2015 Edition) is hereby publicized for three months Please study and verify carefully In case of any objection, please send a letter in time with relevant instructions, experimental data and contact information If there is no opinion at the expiration of the publicity period, it shall be deemed that there is no objection to the content of the proposed revised draft Appendix: public draft of Ginkgo biloba extract